Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

The Risk Of Photochemotherapy

G. Stüttgen
Published 1982 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Whether the risks of photochemotherapy outweigh its merits is a vexed and fascinating question, which is unlikely to be resolved for many years,'••'•^•'^•"'•^'•^" In the period 1969-1980 we treated 2,01 3 patients with phototherapy in Berlin; I believe that this work is germane to the continuing debate. We began using phototherapy with meladinine and UV-radiation mainly on vitiligo patients. In 1969 we included patients with diminished tolerance to sunlight. In 1971-72 we adopted the recommendation of ObersteLehn, Mortazawi and Weber, and began using 8-MOP and UV-A in local treatment of psoriasis. Since 1974-75 we practiced systemic treatment with 8-MOP, following tbe recommendations of Parrish, Fitzpatrick, and Wolff.^""''' The indications for treatment were mycosis fungoides and various forms of psoriasis, and, since 1978, physical urticaria and neurodermatitis. The risks of photochemotherapy arise from: (1) The toxic properties of 8-MOP; (2) The action of UV-A radiation; and (3) The molecular-biological effects of UV-A on 8-MOP (especially the Interaction of DNA psoralen with long wave ultraviolet, and the consequent development of monoadducts, etc) In considering these factors one must bear in mind that UV-A penetrates the epidermis, affecting the microcirculation and the flow of blood within tbe blood vessels, and that after local treatment, MOP is absorbed
This paper references
10.1001/ARCHDERM.1979.04010050066049
Discoid lupus erythematosus possibly due to photochemotherapy.
H. Domke (1979)
10.1056/NEJM197412052912301
Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light.
J. Parrish (1974)
10.1038/283523A0
Possible hazards of photochemotherapy for psoriasis
B. Bridges (1980)
10.1056/NEJM197904123001509
Risks and benefits of the treatment of psoriasis.
J. Epstein (1979)
10.1111/1523-1747.EP12541294
Augmentation of oral methoxsalen-photochemotherapy with an oral retinoic acid derivative.
P. Fritsch (1978)
Risks and benefitsof the treatment of psoriasis
EpsteinJH (1979)
10.1056/NEJM197904123001501
Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis.
R. Stern (1979)
Behandlung der Basaliome und Spinaliome mit lokaler Anwendung von 8 - MOP und BlackLight
Mortazawi SAM (1979)
10.1016/S0190-9622(81)70032-X
Skin cancer in the PUVA-48 cooperative study.
H. Roenigk (1981)
Lokalisierte Blasen bei Fotochemotherapie—Eine akrobullose Fotodermatose
G Heidbreder (1980)
Pharmacokinetics of 8-methoxypsoralen after oral and local application
W Schalla (1976)
10.1001/ARCHDERM.1979.04010020049015
Bowen's disease and squamous cell carcinoma. Occurrence in a patient with psoriasis after topical, systemic, and PUVA therapy.
D. W. Tam (1979)
10.1146/ANNUREV.PA.20.040180.001315
Psoralen photochemotherapy of cutaneous disorders.
T. Anderson (1980)
Voorhees ||: Pathophysiology of psoriasis
(1977)
10.1001/ARCHDERM.1976.01630310005001
Photochemotherapy for psoriasis with orally administered methoxsalen.
K. Wolff (1976)
Nevus spilus-like hyperpigmentation in psoriatic lesions during PUVA therapy.
S. Helland (1980)
10.1111/j.1365-2133.1979.tb05568.x
Nail pigmentation due to oral 8‐methoxypsoralen
R. Naik (1979)
Praktische Erfahrungen mit verschiedenen Phototherapieformen der Psoriasis—PUVA-, SUP-, Teer-UV-Therapie
H Pullmann (1978)
10.1136/BMJ.2.6181.20
Contact allergy to methoxsalen.
E. Saihan (1979)
Influence of a systemically administered aromatic retinoid (Ro 10-9359) on the light sensitivity.
H. Ippen (1978)
10.1001/ARCHDERM.1979.04010080052026
Bullous pemphigoid. Occurrence in psoriasis treated with psoralens plus long-wave ultraviolet radiation.
E. Abel (1979)
10.1001/ARCHDERM.1979.04010050001001
Epidermal dystrophy. Occurrence after psoriasis therapy with psoralen and long-wave ultraviolet light.
A. Cox (1979)
Wasserdampfmessungen der Haut von Psoriatikern unter oraler Photochemotherapie im Vergleich zur selektiven Phototherapie Vortrag ani. des Symposiums des Wissenschaftl
A Wiskemann (1980)
Roenigk HH )r: Skin cancer in the PUVA-48 cooperative study of psoriasis
(1980)
EpsteinJH: Risks and benefitsof the treatment of psoriasis
(1979)
Hirsutismus als seltene Kimplika - tion der PUVA - Therapie
H Heise
[Oral 8-methoxypsoralen-UVA (PUVA) therapy in psoriasis: comparison of 3 treatment protocols].
C. Hofmann (1980)
First results of therapy with long wave UV after photosensitization of skin
H Tronnier
First results of therapy with long wave UV after photosensitization of skin. Presented at Int Cong Photobiol, 6th
H Tronnier
10.1159/000250595
Polyploidization and hemiploidization induced by PUVA in vivo.
A. Omar (1979)
Swanbeck G: Personal information
E M Saihan (1979)
Severe skin pain following PUVA.
J. Miller (1980)
Fundamental and cellular aspects of cutaneous photosensitivity reactions (cell membrane changes)
IC Harber (1974)
Orale 8-MethoxpsoralenUVA-(PUVA) Therapie bei Psoriasis: Vergleich dreir Behandlungsprotokolle
C Hofmann (1980)
10.1001/ARCHDERM.1979.04010100057025
Cataracts in a patient with vitiligo who received photochemotherapy.
A. Pedvis-Leftick (1979)
Photocbemotherapy of psoriasis with oral methoxsalen and long wave ultraviolet light
JA Parrish (1974)
10.1177/014107687907200610
Photochemotherapy in Psoriasis: A Review
D. V. Briffa (1979)
10.1111/j.1440-0960.1980.tb00161.x
THE COMBINATION OF ORAL AND TOPICAL PSORALEN WITH UVA
E. Lobel (1980)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar